Zoladex (ICI 118,630): Clinical trial of new luteinizing hormone-releasing hormone analog in metastatic prostatic carcinoma
Author:
Publisher
Elsevier BV
Subject
Urology
Reference21 articles.
1. Physiologic basis for hormonal therapy in carcinoma of the prostate;Walsh;Urol Clin North Am,1975
2. Endocrine control of prostatic carcinoma;Nesbitt;JAMA,1950
3. Treatment and survival of patients with cancer of the prostate;Surg Gynecol Obstet,1967
4. Diagnostic and therapeutic uses of gonadotropin-releasing hormone;Hammond;Arch Intern Med,1985
5. Gonadotropin hormone-releasing hormone analogues: a new therapeutic approach for prostate carcinoma;Eisenberger;J Clin Oncol,1986
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Risk of Testosterone Flare in the Era of the Saturation Model: One More Historical Myth;European Urology Focus;2019-01
2. Risk of disease flare with LHRH agonist therapy in men with prostate cancer: Myth or fact?;Urologic Oncology: Seminars and Original Investigations;2015-01
3. Serum Testosterone Suppression and Potential for Agonistic Stimulation During Chronic Treatment With Monthly and 3-month Depot Formulations of Leuprolide Acetate for Advanced Prostate Cancer;Journal of Urology;2002-09
4. Serum Testosterone Suppression and Potential for Agonistic Stimulation During Chronic Treatment With Monthly and 3-month Depot Formulations of Leuprolide Acetate for Advanced Prostate Cancer;The Journal of Urology;2002-09
5. Is the flare phenomenon clinically significant?;Urology;2001-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3